Combination therapies with Gabapentin and agents such as corticosteroids or TLR4 antagonists also warrant exploration, with careful attention to comorbidities like BBB disruption or cardiovascular disease, which may affect drug safety and response. Here, TLR4 is linked to cardiovascular disorder.